[
  {
    "ts": "2026-02-16T14:54:00+00:00",
    "headline": "Prothena Stock Tumbles 36.8% Year Over Year: What Lies Ahead?",
    "summary": "PRTA stock declines 36.8% in a year as birtamimab's failure, earnings miss and reliance on partner programs weigh on investor confidence.",
    "url": "https://finance.yahoo.com/news/prothena-stock-tumbles-36-8-145400624.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "7f2af718-2529-3009-9454-1282e9f3ede3",
      "content": {
        "id": "7f2af718-2529-3009-9454-1282e9f3ede3",
        "contentType": "STORY",
        "title": "Prothena Stock Tumbles 36.8% Year Over Year: What Lies Ahead?",
        "description": "",
        "summary": "PRTA stock declines 36.8% in a year as birtamimab's failure, earnings miss and reliance on partner programs weigh on investor confidence.",
        "pubDate": "2026-02-16T14:54:00Z",
        "displayTime": "2026-02-16T14:54:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EzN04L.MG5n2SiOn76bXjg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1EIdoTL1xBchT1nrSboC2Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/prothena-stock-tumbles-36-8-145400624.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/prothena-stock-tumbles-36-8-145400624.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PRTA"
            },
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "RHHBY"
            },
            {
              "symbol": "RHHVF"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-16T16:45:00+00:00",
    "headline": "Merck Indicates Better Growth Visibility in Post-Keytruda LOE Period",
    "summary": "MRK outlines solid long-term outlook with more than $70B opportunity beyond Keytruda LOE, backed by pipeline progress, new product launches and M&A deals.",
    "url": "https://finance.yahoo.com/news/merck-indicates-better-growth-visibility-164500197.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "738f45aa-b6f8-30f1-8cf3-7ad1cc8b1f9d",
      "content": {
        "id": "738f45aa-b6f8-30f1-8cf3-7ad1cc8b1f9d",
        "contentType": "STORY",
        "title": "Merck Indicates Better Growth Visibility in Post-Keytruda LOE Period",
        "description": "",
        "summary": "MRK outlines solid long-term outlook with more than $70B opportunity beyond Keytruda LOE, backed by pipeline progress, new product launches and M&A deals.",
        "pubDate": "2026-02-16T16:45:00Z",
        "displayTime": "2026-02-16T16:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/1b28b8f55ab25205feceb1a2771a2b3a",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RRg0vYpNavphT7S8O9jT7w--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1b28b8f55ab25205feceb1a2771a2b3a.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hIkvgr9e5vaptAEV_vkcVg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1b28b8f55ab25205feceb1a2771a2b3a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-indicates-better-growth-visibility-164500197.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-indicates-better-growth-visibility-164500197.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "RHHBY"
            },
            {
              "symbol": "RHHVF"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-16T10:00:00+00:00",
    "headline": "Theranostics earmarked as “the future” of radiopharmaceuticals",
    "summary": "As RLTs and theranostics gain prevalence, companies must consider how to overcome their associated regulatory, manufacturing and reimbursement hurdles.",
    "url": "https://www.pharmaceutical-technology.com/features/theranostic-radiopharmaceuticals-future-of-radiopharma/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "ae3d3c06-2cff-3079-bc27-5b99d69e200c",
      "content": {
        "id": "ae3d3c06-2cff-3079-bc27-5b99d69e200c",
        "contentType": "STORY",
        "title": "Theranostics earmarked as “the future” of radiopharmaceuticals",
        "description": "",
        "summary": "As RLTs and theranostics gain prevalence, companies must consider how to overcome their associated regulatory, manufacturing and reimbursement hurdles.",
        "pubDate": "2026-02-16T10:00:00Z",
        "displayTime": "2026-02-16T10:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/4120e5008e4f3b4367f0d27a17a1531c",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Theranostic radiopharmaceuticals marry therapeutic and diagnostic principles to facilitate precise and imaging-driven cancer treatment. Image credit: pang_oasis via ShutterStock.com.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Cd7Gsyjq8E1otlkyjmKtag--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/4120e5008e4f3b4367f0d27a17a1531c.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7.zNa.sAIe1acPUOuypbIg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/4120e5008e4f3b4367f0d27a17a1531c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/features/theranostic-radiopharmaceuticals-future-of-radiopharma/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/theranostics-earmarked-future-radiopharmaceuticals-100000265.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVS"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-16T19:11:00+00:00",
    "headline": "What to Expect From These Drug/Biotech Players This Earnings Season?",
    "summary": "Let's take a closer look at what awaits Bausch Health, Amicus Therapeutics, BioMarin Pharmaceutical, Insmed and Madrigal Pharmaceuticals as they prepare to report quarterly results this week.",
    "url": "https://finance.yahoo.com/news/expect-drug-biotech-players-earnings-191100754.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "1ab7e215-9658-3b80-8b8b-ae7d31df1368",
      "content": {
        "id": "1ab7e215-9658-3b80-8b8b-ae7d31df1368",
        "contentType": "STORY",
        "title": "What to Expect From These Drug/Biotech Players This Earnings Season?",
        "description": "",
        "summary": "Let's take a closer look at what awaits Bausch Health, Amicus Therapeutics, BioMarin Pharmaceutical, Insmed and Madrigal Pharmaceuticals as they prepare to report quarterly results this week.",
        "pubDate": "2026-02-16T19:11:00Z",
        "displayTime": "2026-02-16T19:11:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/d7sHwZPFV1U3B4BGoNlXfg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/k5CBlnqEqKxZI1S0BuG_ug--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/expect-drug-biotech-players-earnings-191100754.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/expect-drug-biotech-players-earnings-191100754.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BHC"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "NVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]